StockData
Freenome, Inc. logo

Freenome, Inc. (FRNM) stock

FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.93+0.20 (+2.00%)

Close on Nov 19, 2026Market cap $1.10BP/E –Yield –

Freenome net income

Net income is the profit left for shareholders after every expense, interest and tax.

Freenome's net income for the twelve months ending Sep 30, 2026 was $109.43M. For fiscal 2025 it was $837.47K.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$837.47K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$60.11M–
Q2 FY2026Jun 30, 2026-$69.03M–
Q1 FY2026Mar 31, 2026-$63.56M–
Q4 FY2025Dec 31, 2025$181.91M+18434.4%
Q3 FY2025Sep 30, 2025-$64.47M-62767.3%
Q2 FY2025Jun 30, 2025-$58.73M–
Q1 FY2025Mar 31, 2025-$57.87M–
Q3 FY2024Sep 30, 2024$981.48K–
Q2 FY2024Jun 30, 2024$102.88K–

More Freenome figures

See a number that looks wrong?